Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH
The FINANCIAL -- Gilead Sciences, Inc. and Novo Nordisk A/S announced results from a phase 2 proof-of-concept trial. The five-arm ...
ADVERTISEMENT
Tag: Gilead Sciences
Gilead completed acquisition of Immunomedics
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) announced the completion of the previously announced transaction to acquire Immunomedics, Inc. ...
First and only FDA-approved treatment of coronavirus
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Gilead published New Data for the Treatment of HIV in Black Americans
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced 48-week data from the BRAAVE 2020 study, a Phase 3 ...
ADVERTISEMENT
Popular Last 24h
-
Santos’ final statement in court, was a tearful attempt to express remorse while urging leniency
-
Ampersand wins £22m five-year contract at London Zoo
-
Armenia’s Post-War Economic Recovery: Resilience Amid Challenges
-
2025 NFL Draft: Titans Take Cam Ward No. 1, Giants Reshape Roster, Sanders’ Slide Shocks
-
How Structured Interviewing Reduces Bias in Hiring
-
Soft2Bet is inviting talents to shape the future of iGaming
-
KPMG Data Products Survey Reveals Critical Insights on Data Product Success and Challenges
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
